Research programme: myc small molecule inhibitors - Erasca
Alternative Names: ERAS-11; MYC inhibitors - ErascaLatest Information Update: 09 Jun 2023
At a glance
- Originator Erasca
- Class Antineoplastics; Small molecules
- Mechanism of Action Proto oncogene protein c-myc inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer